EMD-45543

Single-particle
3.03 Å
EMD-45543
3D View Gallery
Deposition: 27/06/2024
Map released: 02/07/2025
Last modified: 01/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Overview 3D View Sample Experiment Validation Additional data Links

EMD-45543

Archive Files (Depositor)

Primary 3D volume (map.gz) Half-map 1 Half-map 2 (map.gz) Experimental metadata (xml) Experimental metadata (cif.gz)

Validation (wwPDB)

Map-only validation report (pdf.gz) Map-9cfe summary report (pdf.gz) Map-9cfe FULL report (pdf.gz)

EMDB Annotations

EMICSS entry mapping (xml)

EMDB Files

VA raw map (map) VA resolution mask (mrc)

Cryo-EM Local Refinement of Antibody 19-77 in complex with prefusion SARS-CoV-2 Spike glycoprotein RBD

EMD-45543

Single-particle
3.03 Å
EMD-45543
3D View Gallery
Deposition: 27/06/2024
Map released: 02/07/2025
Last modified: 01/10/2025
Overview 3D View Sample Experiment Validation Additional data Links
Sample Organism: Severe acute respiratory syndrome coronavirus 2, Homo sapiens
Sample: Antibody 19-77 in complex with prefusion SARS-CoV-2 Spike glycoprotein
Fitted models: 9cfe

Deposition Authors: Casner RG, Shapiro L
Optimizing a human monoclonal antibody for better neutralization of SARS-CoV-2.
Wang Q, Guo Y , Casner RG, Yu J, Nair MS , Ho J, Reddem ER, Mellis IA, Wu M, Tzang CC , Hong H , Huang Y , Shapiro L, Liu L, Ho DD
(2025) Nat Commun , 16 , 6195 - 6195
PUBMED: 40615407
DOI: doi:10.1038/s41467-025-61472-z
ISSN: 2041-1723
Grant Support: